Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of cannabidiol (CBD) for the treatment of chronic pain
Ivan Urits, Kyle Gress, Karina Charipova, et al.
Best Practice & Research Clinical Anaesthesiology (2020) Vol. 34, Iss. 3, pp. 463-477
Closed Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 176
A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
H.M.S. Al Ubeed, Deep Jyoti Bhuyan, Muhammad A. Alsherbiny, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 604-604
Open Access | Times Cited: 83
Cannabidiol - a friend or a foe?
Bianca-Maria Tihăuan, Tatiana Onisei, Walter Slootweg, et al.
European Journal of Pharmaceutical Sciences (2025), pp. 107036-107036
Open Access | Times Cited: 1
Carvone and its pharmacological activities: A systematic review
Lícia Tairiny Santos Pina, Mairim Russo Serafini, Marlange A. Oliveira, et al.
Phytochemistry (2022) Vol. 196, pp. 113080-113080
Closed Access | Times Cited: 50
Pharmacological effects of cannabidiol by transient receptor potential channels
Leila Etemad, Gholamreza Karimi, Mohaddeseh Sadat Alavi, et al.
Life Sciences (2022) Vol. 300, pp. 120582-120582
Closed Access | Times Cited: 44
Neuropathic pain: Mechanisms and therapeutic strategies
Georg Petroianu, Lujain Aloum, Abdu Adem
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 31
Natural sources, biological effects, and pharmacological properties of cynaroside
Abdelhakim Bouyahya, Douae Taha, Taoufiq Benali, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114337-114337
Open Access | Times Cited: 27
Short‐Term Cannabidiol with Δ‐9‐Tetrahydrocannabinol in Parkinson's Disease: A Randomized Trial
Ying Liu, Jacquelyn Bainbridge, Stefan Sillau, et al.
Movement Disorders (2024) Vol. 39, Iss. 5, pp. 863-875
Open Access | Times Cited: 7
A review on packed non-alcoholic beverages: Ingredients, production, trends and future opportunities for functional product development
Suzan Tireki
Trends in Food Science & Technology (2021) Vol. 112, pp. 442-454
Closed Access | Times Cited: 53
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 53
A 2022 Systematic Review and Meta-Analysis of Enriched Therapeutic Diets and Nutraceuticals in Canine and Feline Osteoarthritis
Maude Barbeau-Grégoire, Colombe Otis, Antoine Cournoyer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10384-10384
Open Access | Times Cited: 30
Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
Daphnée Brazeau, Amelie A Deshaies, David Williamson, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e092919-e092919
Open Access
Mitochondria and sensory processing in inflammatory and neuropathic pain
Patrícia Silva Santos Ribeiro, Hanneke L.D.M. Willemen, Niels Eijkelkamp
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 25
Brain stimulation for chronic pain management: a narrative review of analgesic mechanisms and clinical evidence
Michał Szymoniuk, J.K. Chin, Łukasz Domagalski, et al.
Neurosurgical Review (2023) Vol. 46, Iss. 1
Open Access | Times Cited: 15
Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain
Paula Muresan, Stephen G. Woodhams, Fiona Smith, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 49, pp. 102664-102664
Open Access | Times Cited: 13
Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment
Cristiana Dumbraveanu, Katharina Strommer, Meinolf Wonnemann, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 853-853
Open Access | Times Cited: 13
Cannabidiol attenuates periodontal inflammation through inhibiting TLR4/NF‐κB pathway
Hao Chen, Yaqi Liu, Sijing Yu, et al.
Journal of Periodontal Research (2023) Vol. 58, Iss. 4, pp. 697-707
Closed Access | Times Cited: 13
The Role of The Rostral Ventromedial Medulla in Stress Responses
Marco Pagliusi, Felipe V. Gomes
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 776-776
Open Access | Times Cited: 13
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis
Mengdi Sun, Feiyu Zhang, Fang Lü, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis
Zeeta Bawa, Daniel Lewis, Paul Gavin, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Adverse Childhood Experiences and Cannabis Use Among US Adults: Do Poor Health and Disability Influence Types of Cannabis Use?
Constance L. Chapple, Elizabeth M. Green, Helen M. Milojevich, et al.
Substance Use & Misuse (2025), pp. 1-10
Closed Access
Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
Kevin F. Boehnke, Winfried Häuser, Mary‐Ann Fitzcharles
Current Rheumatology Reports (2022) Vol. 24, Iss. 7, pp. 238-246
Open Access | Times Cited: 20
Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
Anjalika Eeswara, Amanda Pacheco-Spiewak, Stanislava Jergová, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282920-e0282920
Open Access | Times Cited: 11
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats
Gleice Kelli Silva-Cardoso, Willian Lazarini-Lopes, Eduardo Octaviano Primini, et al.
Behavioural Brain Research (2023) Vol. 452, pp. 114588-114588
Closed Access | Times Cited: 10
A Pilot Study on Cannabidiol (CBD) and Eccentric Exercise: Impact on Inflammation, Performance, and Pain
Whitley J. Stone, Danilo V. Tolusso, Guiellermo Pancheco, et al.
International journal of exercise science (2023) Vol. 16, Iss. 2
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top